Dual CAR-T cells were generated by Shu et al. to co-target CD-47 and TAG-72, an aberrantly glycosylated glycoprotein overexpressed in adenocarcinomas such as ovarian cancer. This evidence concerns the gene CD47 and ovarian carcinoma.